SPECIAL NOTICE
99 -- Briefing to Industry on the Advance Anticonvulsant System (AAS) and the Improved Nerve Agent Treatment Systems Program (INATS)
- Notice Date
- 2/3/2005
- Notice Type
- Special Notice
- Contracting Office
- US Army Space and Missile Defense Command, Deputy Commander, ATTN SMDC-CM-AP, P.O. Box 1500, Huntsville, AL 35807-3801
- ZIP Code
- 35807-3801
- Solicitation Number
- USA-SNOTE-050203-003
- Archive Date
- 4/4/2005
- Description
- The Medical Identification and Treatment Systems Product Manager of the Chemical, Biological, and Medical Project Management Office, is hosting a briefing to interested prospective offerors to present current information on the AAS and INATS programs . The briefing will be held on March 8, 2005, 9AM to 3PM at CBMS Joint PMO, 64 Thomas Johnson Drive, Frederick, Maryland. The MITS Pharmaceutical Manager will discuss the advance development of the AAS and INATS necessary to provide warfighters with prote ction against the toxic effects of exposure to nerve. Midazolam will be administered with a single-chambered autoinjector in the AAS program while atropine and an oxime will be sequentially administered by a 2-chambered autoinjector in the INATS program. Participants should expect to obtain specific information on the autoinjector-related work required for both programs. A question and answer session will be held following the briefing. This release of information is open to any interested prospective o fferor and all are encouraged to attend. To reserve a space in this briefing, email your request to participate to Dr. George Schieferstein using the following email address: George.Schieferstein@det.amedd.army.mil.
- Web Link
-
List of MITS Products
(http://www.jpeocbd.osd.mil/page_manager.asp?pg=2&sub=4)
- Record
- SN00745318-W 20050205/050203212247 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |